Fu Biqian, Xi Shengyan, Wang Yanhui, Zhai Xiangyang, Wang Yanan, Gong Yuewen, Xu Yangxinzi, Yang Jiaqi, Qiu Yingkun, Wang Jing, Lu Dawei, Huang Shuqiong
Department of Traditional Chinese Medicine, Medical College, Xiamen University, Xiamen, China.
Cancer Research Center, Xiamen University, Xiamen, China.
Front Pharmacol. 2019 Jan 8;9:1539. doi: 10.3389/fphar.2018.01539. eCollection 2018.
Ciji-Hua'ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice with transplanted H hepatocellular carcinoma were employed in this study. Ninety-two mice were injected subcutaneously with H HCC cell suspension into the right anterior armpit. After mice were treated with 5-fluorine pyrimidine (5-FU), they were divided into six groups as untreated group, 5-FU group, 5-FU plus Yangzheng Xiaoji Capsule group and three groups of 5-FU plus different concentrations of CHB-II-F. Twenty mice were euthanized after 7 days of treatment in untreated and medium concentration of CHB-II-F groups and all other mice were euthanized after 14 days of treatment. Herbal components/metabolites were analyzed by UPLC-MS. Tumors were evaluated by weight and volume, morphology of light and electron microscope, and cell cycle. Apoptosis were examined by apoptotic proteins expression by western blot. Four major components/metabolites were identified from serum of mice treated with CHB-II-F and they are β-Sitosterol, Salvianolic acid, isobavachalcone, and bakuchiol. Treatment of CHB-II-F significantly increased body weights of mice and decreased tumor volume compared to untreated group. Moreover, CHB-II-F treatment increased tumor cells in G-G transition instead of in S phase. Furthermore, CHB-II-F treatment increased the expression of pro-apoptotic proteins and decreased the expression anti-apoptotic protein. Therefore, CHB-II-F could improve mice general condition and reduce tumor cell malignancy. Moreover, CHB-II-F regulates apoptosis of tumor cells, which could contribute its protective effect on chemotherapy.
慈济化癌保生二号方(CHB-II-F)是一种中药方剂,临床实践表明其可缓解化疗副作用并提高癌症患者的生活质量。为了解其对化疗的保护作用机制,本研究采用移植H肝癌的小鼠。92只小鼠右前腋下皮下注射H肝癌细胞悬液。小鼠用5-氟尿嘧啶(5-FU)治疗后,分为六组,即未治疗组、5-FU组、5-FU加养正消积胶囊组以及5-FU加不同浓度CHB-II-F的三组。未治疗组和中浓度CHB-II-F组治疗7天后处死20只小鼠,其他所有小鼠治疗14天后处死。通过超高效液相色谱-质谱联用仪分析草药成分/代谢产物。通过重量和体积、光镜和电镜形态以及细胞周期评估肿瘤。通过蛋白质印迹法检测凋亡蛋白表达来检查细胞凋亡。从用CHB-II-F治疗的小鼠血清中鉴定出四种主要成分/代谢产物,它们是β-谷甾醇、丹酚酸、异补骨脂查尔酮和补骨脂酚。与未治疗组相比,CHB-II-F治疗显著增加了小鼠体重并减小了肿瘤体积。此外,CHB-II-F治疗使肿瘤细胞在G-G期转变增加,而非S期。此外,CHB-II-F治疗增加了促凋亡蛋白的表达并降低了抗凋亡蛋白的表达。因此,CHB-II-F可改善小鼠一般状况并降低肿瘤细胞恶性程度。此外,CHB-II-F调节肿瘤细胞凋亡,这可能有助于其对化疗的保护作用。